Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2022-2028
As per Triton Market
Research’s report, the Middle East and Africa cough syrup market is estimated
to grow with a CAGR of 2.86% during
the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in this region include:
•
The United Arab Emirates
•
Saudi Arabia
•
Turkey
•
South Africa
•
Rest of Middle East & Africa
In
the region, Turkey captures the highest share in the cough syrup market. The high rate of tobacco smoking is a major
cause of respiratory diseases in the region. Moreover, an increase in obesity
levels has resulted in associated lung diseases among a majority of people.
Furthermore, asthma, lung cancer, and occupational lung disease have emerged as
major respiratory diseases affecting a large section of the population.
Therefore, the increase in respiratory diseases fuels the cough syrup market
across the region.
Turkey has witnessed a significant rise in the
aging population, along with a surge in non-communicable diseases. Moreover,
the country has observed COPD and lung disease as major causes of mortality. As
per WHO, lung disease is responsible for a significant number of deaths
nationwide. These factors have highlighted the need for cough syrups across the
country. Therefore, as mentioned above, these factors are driving the cough
syrup market across Turkey.
In Saudi Arabia, the prevalence of COPD is
around 14.2% among smokers. Moreover, the prevalence of respiratory allergies
has increased in the country over the recent years. The nation’s population is
heavily exposed to biomass fuel, dust, gases, and other air pollutants, which
has increased respiratory allergies. The rise in air pollution has also led to
TB, chronic asthma, respiratory tract infection, and others. Therefore, these
factors widen the scope and growth of the cough syrup market.
Pediatric cough syrups include dextromethorphan
as a common ingredient. This cough syrup is to cure cough caused by common cold
and other factors among children between 6 to 12 years old. Pediatric cough
syrups help relieve symptoms such as blocked nose, congestion, sneezing, and
watery eyes. The market’s growth is
evaluated based on product type, age group, and distribution channel. In
terms of age group, it is bifurcated into pediatric and adult.
Some
of the prominent companies in the cough syrup market include Sanofi SA, Merck
KGaA, The Himalaya Drug Company, Reckitt Benckiser Group Plc, and Novartis
International AG.
Sanofi SA is a pharmaceutical company that
manufactures and markets healthcare products. The group provides numerous
products related to rare diseases, oncology, diabetes, and cardiovascular
diseases. Moreover, the company offers prescription products, consumer healthcare,
generics, and vaccines. Additionally, the company develops combination drugs
and biologics with precision. Sanofi has operations in numerous regions,
including the Middle East and Africa.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the cough syrup market
revenue growth in the Middle East and Africa and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the Middle
East and Africa cough syrup market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
1. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE COUGH SYRUP MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
DEMAND FOR HERBAL COUGH SYRUPS
2.2.2. COMPANIES
PROVIDE SUGAR-FREE COUGH SYRUPS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
CHRONIC RESPIRATORY DISEASES
2.7.2. RISE
IN OLDER POPULATION
2.8. MARKET
CHALLENGES
2.8.1. OVERDOSE
RISK
2.8.2. STRICT
GOVERNMENT REGULATIONS AND RESTRICTIONS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASE
IN CHILD-FRIENDLY COUGH SYRUP FLAVORS
2.9.2. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9.3. SPECIAL
PEDIATRIC COUGH SYRUPS
3. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS/ANTITUSSIVES
3.2. COMBINATION
MEDICATIONS
3.3. EXPECTORANTS
4. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP
4.1. ADULT
4.2. PEDIATRIC
5. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACY
5.2. HOSPITAL
PHARMACY
5.3. ONLINE
PHARMACY
6. MIDDLE
EAST AND AFRICA COUGH SYRUP MARKET – COUNTRY OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. SAUDI
ARABIA
6.3. TURKEY
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ACELLA
PHARMACEUTICALS LLC
7.3. ASTRAZENECA
PLC
7.4. CIPLA
LIMITED
7.5. DABUR
INDIA LTD
7.6. GLAXOSMITHKLINE
7.7. GLENMARK
PHARMACEUTICALS LIMITED
7.8. JOHNSON
AND JOHNSON
7.9. MERCK
KGAA
7.10. NOVARTIS
INTERNATIONAL AG
7.11. PFIZER
INC
7.12. PROCTOR
AND GAMBLE CO
7.13. RECKITT
BENCKISER GROUP PLC
7.14. SANOFI
SA
7.15. THE
HIMALAYA DRUG COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: THE COUNTRIES WITH
THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020
TABLE 4: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $
MILLION)
FIGURE 4: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)
FIGURE 7: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)
FIGURE 10: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 14: UNITED ARAB
EMIRATES COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE 15: SAUDI ARABIA COUGH
SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: TURKEY COUGH SYRUP
MARKET 2022-2028 (IN $ MILLION)
FIGURE 17: SOUTH AFRICA COUGH
SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE 18: REST OF MIDDLE EAST
& AFRICA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)